Gore lawyer David Boies, intimidate his sources with lawsuit threats. The author's investigation is part of the story: as he pursues the truth, Theranos's attorneys, led by Bush v. The reality, he reports, was less stellar: the company's flawed tests did not meet regulatory standards and gave dangerously inaccurate results, investors and journalists were snowed with fake demos, and Holmes and her second-in-command (and boyfriend), Sunny Balwani, dismissed employees' concerns and drove many out with verbal abuse and computer surveillance. Her start-up became the toast of Silicon Valley, with a $9 billion valuation and a board including former secretaries of state Henry Kissinger and George Shultz. Expanding on his award-winning investigative scoops, Pulitzer-winning Wall Street Journal reporter Carreyrou recounts how Elizabeth Holmes, a charismatic Stanford dropout, started Theranos with claims of a revolutionary blood-testing technology that needed just a few drops from a finger-prick rather than tubefulls drawn from veins with needles. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees.Īn apparent scientific breakthrough rests on a quicksand of deception in this riveting account of the rise and downfall of notorious biotech firm Theranos. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. There was just one problem: The technology didn’t work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood.

Carreyrou tells virtually to perfection.” - The New York Times Book Review With a new Afterword covering her trial and sentencing, bringing the story to a close.

The gripping story of Elizabeth Holmes and T heranos -one of the biggest corporate frauds in history-a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist.

John carreyrou theranos book